Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (121-130 of 319) with videos related to

Pageof 32
Sort By:
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Urology|July 17, 2019
Evaluation of Asymptomatic Microscopic Hematuria by Renal Ultrasound to Detect Upper Tract Malignancy: A 20-Year Experience in a Community HospitalMatthew R Smith, Keaton C Read, Matthew L Stegman, et al.
The Journal of Urology|January 13, 2006
Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancerMatthew R Smith, Simone Peart Boyce, Erick Moyneur, et al.
Nature Communications|September 27, 2018
Predicting nutrient content of ray-finned fishes using phylogenetic informationBapu Vaitla, David Collar, Matthew R Smith, et al.
Magnetic Resonance in Medicine|April 8, 2016
Accelerating fully phase-encoded MRI near metal using multiband radiofrequency excitationNathan S Artz, Curtis N Wiens, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body compositionMatthew R Smith, Melissa Goode, Anthony L Zietman, et al.
The Journal of Organic Chemistry|November 20, 2009
Carbene reactivity of 4-diazo-4H-imidazoles toward nucleophiles and aromatic compoundsMatthew R Smith, Alexander J Blake, Christopher J Hayes, et al.
BMC Cancer|August 8, 2009
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidityPierre P Major, Richard J Cook, Allan Lipton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancerPhilip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
Future Oncology (London, England)|March 25, 2025
Prostate-specific antigen (PSA) response with darolutamide in metastatic hormone-sensitive prostate cancer and its impact on treatment outcomes in the ARASENS trial: a plain language summaryFred Saad, Maha H A Hussain, Bertrand Tombal, et al.
Pageof 32

Showing results (121-130 of 319) with videos related to

Sort By:
Pageof 32
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Urology|July 17, 2019
Evaluation of Asymptomatic Microscopic Hematuria by Renal Ultrasound to Detect Upper Tract Malignancy: A 20-Year Experience in a Community HospitalMatthew R Smith, Keaton C Read, Matthew L Stegman, et al.
The Journal of Urology|January 13, 2006
Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancerMatthew R Smith, Simone Peart Boyce, Erick Moyneur, et al.
Nature Communications|September 27, 2018
Predicting nutrient content of ray-finned fishes using phylogenetic informationBapu Vaitla, David Collar, Matthew R Smith, et al.
Magnetic Resonance in Medicine|April 8, 2016
Accelerating fully phase-encoded MRI near metal using multiband radiofrequency excitationNathan S Artz, Curtis N Wiens, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body compositionMatthew R Smith, Melissa Goode, Anthony L Zietman, et al.
The Journal of Organic Chemistry|November 20, 2009
Carbene reactivity of 4-diazo-4H-imidazoles toward nucleophiles and aromatic compoundsMatthew R Smith, Alexander J Blake, Christopher J Hayes, et al.
BMC Cancer|August 8, 2009
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidityPierre P Major, Richard J Cook, Allan Lipton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancerPhilip J Saylor, Umar Mahmood, Anchisa Kunawudhi, et al.
Future Oncology (London, England)|March 25, 2025
Prostate-specific antigen (PSA) response with darolutamide in metastatic hormone-sensitive prostate cancer and its impact on treatment outcomes in the ARASENS trial: a plain language summaryFred Saad, Maha H A Hussain, Bertrand Tombal, et al.
Pageof 32